B
Bryan Burmeister
Researcher at Princess Alexandra Hospital
Publications - 163
Citations - 8693
Bryan Burmeister is an academic researcher from Princess Alexandra Hospital. The author has contributed to research in topics: Radiation therapy & Chemoradiotherapy. The author has an hindex of 39, co-authored 158 publications receiving 7908 citations. Previous affiliations of Bryan Burmeister include Sir Charles Gairdner Hospital & University of Queensland.
Papers
More filters
Book ChapterDOI
Esophagus Carcinoma Surveillance Counterpoint: Australia
TL;DR: The demographics of esophageal cancer in Australia reflect those of other Western countries with a rising incidence in adenocarcinoma of the lower esophagus and esophago-gastric junction and there are some data to suggest that neoadjuvant chemoradiation therapy results in downstaging and improves resectability.
Journal ArticleDOI
Radiation-Therapy for the Management of Localized Prostate Carcinoma
Bryan Burmeister,J. C. Probert +1 more
TL;DR: Radiation therapy for localized prostate carcinoma is effective, with a high rate of local control and low morbidity, and histology was a significant factor in local control.
Journal ArticleDOI
SO-5 Disease-free survival as surrogate for overall survival in neoadjuvant chemo(radio)therapy treatment of esophageal or gastro-esophageal junction carcinoma: An analysis of 4518 individual patients and 22 trials
N. Cabrit,Matthieu Faron,J. Tierney,Maurice Cheugoua-Zanetsie,Pierre Thirion,David Cunningham,Kyle Winter,Jiaqi Fu,Murielle Mauer,J. Shapiro,Bryan Burmeister,Tom Walsh,Guillaume Piessen,Fredrik Klevebro,Marc Ychou,A. van der Gaast,Simon Law,Marian Stahl,Xavier Paoletti,Michel Ducreux,Stefan Michiels +20 more
TL;DR: In this paper , the authors used individual patient data from a network meta-analysis of neoadjuvant chemotherapy or chemoradiotherapy in esophageal or gastro-esophagal junction carcinoma (MANATEC-02) to evaluate the time between recurrence and death in each trial.
Journal ArticleDOI
Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma.
Matthieu Faron,Maurice Cheugoua-Zanetsie,Jayne F. Tierney,Matthew Nankivell,Kathryn Winter,Joel Shapiro,Dewi Vernerey,Thomas N. Walsh,Guillaume Piessen,Magnus Nilsson,Marc Ychou,Simon Law,Florent de Vathaire,Michael Stahl,Bryan Burmeister,Xavier Paoletti,Johanna W. van Sandick,Jianhua Lu,Michel Ducreux,C Apinop,Emilie Barbier,Gary A. Bass,Pierre Blanchard,Jurjen J. Boonstra,Jean-François Bosset,Armel Maurice Cheugoua-Zanetsie,David Cunningham,Val Gebski,D J Girling,David P. Kelsen,Fredrik Klevebro,Elisabeth Le Prisé,Florian Lordick,Tanaphon Maipang,Murielle Mauer,Stefan Michiels,Jennifer Moughan,Knut Nygaard,Patrick W. Owens,Jean-Pierre Pignon,Jean-Luc Raoul,Jack A. Roth,Alberto Ruol,Peter M. Schlag,Christoph Schumacher,B. Mark Smithers,Joel E. Tepper,Pierre Thirion,Janine Thomas,Susan G. Urba,Michele Valmasoni,A. van der Gaast,D. Williaume,John Wong,Huanming Yang +54 more
TL;DR: This paper performed an individual participant data (IPD) network meta-analysis (NMA) of randomized controlled trials (RCTs) to study the effect of chemotherapy or chemoradiotherapy, with a focus on tumor location and histology subgroups.
Journal ArticleDOI
Malignant Broncho-Oesophageal Fistula following Radiotherapy for Noninvasive T3 Oesophageal Squamous Cell Carcinoma
Dwayne Reading,Bryan Burmeister +1 more
TL;DR: A 71-year-old female with a T3 oesophageal squamous cell carcinoma, who presented with new onset dysphagia 2 weeks after completing a course of definitive radiotherapy and was found to have a broncho-oesophageaal fistula is reported.